![](https://www.pdfsearch.io/img/3abd042d944c27154c43a660a3cb407f.jpg) Date: 2014-09-25 16:16:58
| | Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M CatheAdd to Reading ListSource URL: s3.amazonaws.comDownload Document from Source Website File Size: 460,20 KBShare Document on Facebook
|